Journal of occupational and environmental medicine · 2025
COVID-19 Workplace Testing Study: Phase II Analysis.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nessim Dalia, Thiese Matthew, Ball Cynthia, Levin Jeffrey, Moore Kevin, Parvanta Claudia, Caban Martinez Alberto J, Eastlake Adrienne, Schulte Paul
Аннотация
BACKGROUND: US businesses were considerably impacted by the COVID-19 pandemic. Return to work after exposure or illness was challenging.
OBJECTIVE: This study aimed to assess employers' experiences and perspectives during the pandemic with SARS-CoV-2 testing in their workforce.
METHODS: An anonymous survey was delivered to employers across nine NORA sectors. Data were analyzed using SAS Version 9.4.
RESULTS: Thirty percent of the respondents worked in a small-sized company (<100 employees), 28% were 100-500 employees, and 42% were more than 500. Small, medium, and large companies were differentially affected, with larger companies affected the most. Sixty-eight percent reported utilizing testing in their return-to-work strategy. Delay in getting results was the most common reported barrier to testing during the early phase of the pandemic (60%).
CONCLUSION: This study will help prepare employers in return-to-work testing decisions in future pandemics.
OBJECTIVE: This study aimed to assess employers' experiences and perspectives during the pandemic with SARS-CoV-2 testing in their workforce.
METHODS: An anonymous survey was delivered to employers across nine NORA sectors. Data were analyzed using SAS Version 9.4.
RESULTS: Thirty percent of the respondents worked in a small-sized company (<100 employees), 28% were 100-500 employees, and 42% were more than 500. Small, medium, and large companies were differentially affected, with larger companies affected the most. Sixty-eight percent reported utilizing testing in their return-to-work strategy. Delay in getting results was the most common reported barrier to testing during the early phase of the pandemic (60%).
CONCLUSION: This study will help prepare employers in return-to-work testing decisions in future pandemics.